Limited Competition for Continuation of Induced Pluripotent Stem Cell (iPSC) Resources promoting Translational Research Advancements in Neurodegenerative Diseases (U24)

The summary for the Limited Competition for Continuation of Induced Pluripotent Stem Cell (iPSC) Resources promoting Translational Research Advancements in Neurodegenerative Diseases (U24) Federal Grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the government agency that is offering this grant.
Federal Grant Title: Limited Competition for Continuation of Induced Pluripotent Stem Cell (iPSC) Resources promoting Translational Research Advancements in Neurodegenerative Diseases (U24)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-NS-11-011
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.853
CFDA Descriptions: Extramural Research Programs in the Neurosciences and Neurological Disorders
Current Application Deadline: Jun 22, 2011
Original Application Deadline: Jun 22, 2011
Posted Date: Apr 14, 2011
Creation Date: Apr 14, 2011
Archive Date: Jul 23, 2011
Total Program Funding:
Maximum Federal Grant Award: $1,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Grant Description
The National Institute of Neurological Disorders and Stroke (NINDS) invites applications for a limited competition Funding Opportunity Announcement (FOA) utilizing a Cooperative Agreement (U24) to provide continuing support for consortia originally funded through the American Recovery and Reinvestment Act of 2009 (ARRA) to develop well characterized, broadly available induced pluripotent stem cell (iPSC) resources for neurodegenerative diseases. A primary goal of this new initiative is to facilitate the scientific evaluation of iPSC resources for drug discovery purposes and to increase the number of lines, types of mutations, reporter modifications, maintenance and differentiation protocols and cell line characterization that are broadly available to the community as research resources. This Initiative is intended to be a partnership with government, non-government organizations and pharmaceutical companies interested in advancing drug discovery efforts for neurodegenerative diseases.
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Foreign (non-U.S.) components of U.S. Organizations are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/rfa-ns-11-011.html
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for B...
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for B...
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechno...
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechno...
Career Transition Award for NINDS Intramural Clinician-Scientists (K22)
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (K23)
Paul B. Beeson Clinical Scientist Development Award in Aging (K08)
Bioreactors for Reparative Medicine (R43/R44)
Bioreactors for Reparative Medicine (R41/R42)
Bioreactors for Reparative Medicine - SBIR Direct Phase II (R44)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com